title: Levodopa induces synthesis of nerve growth factor and growth hormone in patients with Parkinson disease.
abstract: BACKGROUND
  Polyneuropathy is observed in treated patients with Parkinson disease. Peripheral axonal degeneration is related to nerve growth factor metabolism. The causes for this axonal degeneration and the role of levodopa itself are not known. Levodopa may experimentally exert supportive effects on nerve growth factor synthesis and on growth hormone production, a hormonal compound with regenerative potential.
  
  
  OBJECTIVE
  The objective of this study was to investigate the effects of soluble 250-mg levodopa/benserazide administration on plasma occurrence of levodopa, nerve growth factor, and growth hormone in patients with Parkinson disease over an interval of 60 minutes.
  
  
  RESULTS
  Levodopa moderately increased bioavailability of nerve growth factor and growth hormone combined with the rise of levodopa. Nerve growth factor data and levodopa values correlated to each other.
  
  
  CONCLUSIONS
  Axonal degeneration may not be due to levodopa itself, as levodopa supports production of nerve growth factor and of growth hormone. Both may complement each other for neuronal survival.
authors.affiliation: Department of Neurology, St Joseph Hospital Berlin-Weissensee, Berlin, Germany. th.mueller@alexius.de
authors.forename: Thomas
authors.initials: T
authors.lastname: Müller
authors.forename: Reiner
authors.initials: R
authors.lastname: Hellwig
authors.forename: Siegfried
authors.initials: S
authors.lastname: Muhlack
mesh_terms: D000368:Aged; D015415:Biomarkers; D019382:Human Growth Hormone / Q000096:biosynthesis* / Q000097:blood*; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D020932:Nerve Growth Factor / Q000096:biosynthesis* / Q000097:blood*; D010300:Parkinson Disease / Q000097:blood* / Q000188:drug therapy
chemical_list: D015415:Biomarkers; D019382:Human Growth Hormone; D007980:Levodopa; D020932:Nerve Growth Factor